PCOH-Plus
92/100
This product looks safe
- Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
- 40% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 250mg is 7.1× the Tolerable Upper Intake Level (35mg)
Label Data
1 Capsule(s)
Serving Size
Other Combinations
Product Type
40%
Evidence Coverage
Supplement Facts — Evidence Check
250 mg
(1250% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 7.1× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Policosanol
10 mg
2.5 mg
📊 Market median: 100.0mg (283 products)
📚 142 studies (Tier A: 1, B: 64)
Superoxide Dismutase
15 mcg
Catalase
15 mcg
Other Ingredients
Gelatin
Water
Glycerin
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
RECOMMENDATION: One (1) capsule taken one (1) or two (2) times each day as a dietary supplement or as otherwise directed by a healthcare professional.
⚠️ Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN
Sealed with an imprinted safety seal for your protection.
🧪 Formulation Notes
Dietary Supplement with Policosanol, Niacin and CoQ10.
Additional Information
Store in a cool, dry area.
Rev. 7/06
Specially grown, biologically active, containing naturally associated and/or organically bound phytochemicals including polyphenolic compounds with SOD and catalase, dehydrated at low temperature to preserve associated enzyme factors.
Product Details
DSLD Entry Date
2013-06-25
Product Type
Other Combinations
Form
Capsule
DSLD ID
22119
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100